Abstract
Since the original description of aortic valve replacement (AVR) with a pulmonary autograft by Donald Ross in 1967, 1 cardiac surgeons have had an uneasy relationship with this method for managing aortic valve disease. In many patients, the implanted autograft functions normally with no evidence of late deterioration, and thus is an ideal valve substitute. The Ross procedure has a special advantage in young children, because the implanted autograft can enlarge with somatic growth. 2 However, the operation is more complicated than standard prosthetic AVR because of the need for careful dissection during harvest of the pulmonary artery graft, the requirement for precise alignment of the graft within the aortic root, and the added potential for late dysfunction of the homograft or heterograft used to replace the native pulmonary valve.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.